Delisting risk
Xenetic Biosciences
Develops DNase-based adjuncts for cancer therapy and armored CAR-T treatment.
$3.98
After-hours close+0.02 (+0.51%)
At close$3.96(−0.25%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | — | — | — |
| Aug 2026 | — | −$0.41 | — |
| Aug 2026 | — | −$0.41 | — |
| May 2026 | — | −$0.20 | — |
| Mar 2026 | −$0.52 | −$0.22 | +57.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | — | — | — | — | — | — |
| Aug 7, 2026 | — | −$0.41 | — | — | $660.6K | — |
| Aug 6, 2026 | — | −$0.41 | — | — | $660.6K | — |
| May 12, 2026 | — | −$0.20 | — | — | $806.9K | — |
| Mar 12, 2026 | −$0.52 | −$0.22 | +57.7% | $690.0K | $766.3K | +11.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Nov 12, 2025 | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 9, 2024 | ||||||
| Mar 21, 2024 | ||||||
| Nov 10, 2023 | ||||||
| Aug 11, 2023 | ||||||
| May 11, 2023 | ||||||
| Mar 23, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Aug 12, 2022 | ||||||
| May 12, 2022 | ||||||
| Mar 22, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 12, 2021 | ||||||
| Mar 16, 2021 | ||||||
| Nov 12, 2020 | ||||||
| Aug 12, 2020 | ||||||
| May 14, 2020 | ||||||
| Mar 26, 2020 | ||||||
| Nov 15, 2019 | ||||||
| Aug 15, 2019 | ||||||
| May 10, 2019 | ||||||
| Mar 29, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 10, 2018 | ||||||
| May 15, 2018 | ||||||
| Mar 30, 2018 | ||||||
| Nov 15, 2017 | ||||||
| Aug 14, 2017 | ||||||
| May 16, 2017 | ||||||
| Apr 3, 2017 | ||||||
| Nov 15, 2016 | ||||||
| Aug 15, 2016 | ||||||
| May 16, 2016 | ||||||
| Mar 30, 2016 | ||||||
| Nov 16, 2015 | ||||||
| Aug 19, 2015 | ||||||